Max Walker
University of Wisconsin–Stout(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Cholesterol and Lipid Metabolism, Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development(2008)387 cited
- → Torcetrapib‐induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone(2008)285 cited
- → Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies(2010)86 cited
- Rethinking Connection Security Indicators(2016)
- → Both the Peroxisome Proliferator‐Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL‐Derived Cholesterol(2009)65 cited
- → SCAP ligands are potent new lipid-lowering drugs(2001)61 cited
- → The number of single nucleotide polymorphisms and on-farm data required for whole-herd parentage testing in dairy cattle herds(2008)42 cited
- → Identification of Genetic Variation in the Human Hormone-Sensitive Lipase Gene and 5′ Sequences: Homology of 5′ Sequences with Mouse Promoter and Identification of Potential Regulatory Elements(1998)41 cited
- → Selective Partial Agonism of Liver X Receptor α Is Related to Differential Corepressor Recruitment(2008)31 cited
- → PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI(2011)22 cited